Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Toshihiro Iguchi is a pioneering figure in interventional oncology, whose research centers on the development and clinical translation of robotic systems for computed tomography (CT)-guided needle interventions. His major contributions lie in demonstrating the feasibility, accuracy, and safety of robotic needle insertion for biopsy and ablation procedures, directly addressing the limitations of manual techniques. Dr. Iguchi’s work has been highly influential, with his foundational phantom and animal studies—such as the 2017 paper on robotically driven CT-guided insertion (53 citations)—establishing the technical benchmarks for the field. He led the first prospective first-in-human feasibility trial of robotic CT fluoroscopy–guided biopsy (46 citations), a landmark achievement that validated the clinical potential of this technology. His research further quantified the superior accuracy of robotic out-of-plane needle placement (35 citations) and its adaptability for various ablation needles (39 citations). Notably, Dr. Iguchi developed the "Zerobot" system at his institution, a platform that has become a focal point for subsequent research. Through his narrative reviews (22 citations), he has also synthesized the current state of robotic systems in interventional oncology, guiding future innovation. His cumulative work is driving a paradigm shift toward more precise, minimally invasive cancer interventions.